Synergy CHC (SNYR) - Margin dodolan resik

Logo korporat perusahaan Synergy CHC Corp. (SNYR)

The Synergy CHC Corp (SNYR) business model is based on contract manufacturing of health products and its own logistics centers. The net profit margin demonstrates how this foundation has created a dominant retail ecosystem of wellness brands. The value of -57.00 expresses the current metric value, confirming financial stability. High customer loyalty and the holding's impeccable image complete the formation of the company's reliable investment profile.

Tingkat bathi resik synergychc.com (SNYR): kanggo periode 24.10.2024 - 03.10.2026

Rincian analitis perusahaan Synergy CHC Corp

Ringkesan analitik perusahaan:synergychc.com - SNYR
Produk dadi Synergy CHC

This indicator determines the share of net profit in total revenue, reflecting the actual efficiency of cash flow generation. By analyzing the net profit margin, an investor assesses the business's ability to convert revenue into final capital after deducting all expenses. The metric measures operational resilience and the quality of cost management. For Synergy CHC Corp (SNYR), this is evidenced by the optimization of brand packaging, which reduces expenses without requiring capital expenditures. A rising trend signals increasing profitability but necessitates monitoring the asset's valuation.

Pesaing utama

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik veronapharma.com|Rentabilitas dodolan resik MENS (Jyong Biotech Corp)|Margin resik Ligand (LGND)|Margin dodolan resik amneal.com (AMRX)|Margin dodolan resik PRGO (perrigo.com)|Alvotech SA (ALVO) - Margin resik|Liquidia Inc. - Margin dodolan resik|Tingkat bathi miturut bathi resik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Margin resik|Rentabilitas dodolan resik MNKD|Margin resik Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Margin dodolan perusahaan|Margin dodolan resik SPRY|TBPH - Margin resik|Aquestive Pharma - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik scpharmaceuticals.com SCPH|Tectonic - Margin dodolan resik|TNXP - Margin dodolan resik|SXTC: Margin dodolan resik|Eupraxia Pharma - Tingkat bathi resik|BHST (bioharvest.com) - Margin dodolan resik|Rentabilitas dodolan resik EXOZ (invizyne.com)|Margin dodolan resik ORMP|Margin dodolan perusahaan Entera Bio|Margin dodolan resik HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Margin resik|Cumberland Corp - Margin dodolan resik|QNTM - Margin dodolan resik|FibroGen, Inc. (FGEN) - Margin resik|TELO: Rentabilitas resik perusahaan|RANI (Rani Therapeutics Inc) - Margin dodolan resik|Margin resik rallybio.com RLYB|Margin dodolan resik LEXX|PULM (Pulmatrix, Inc.) - Tingkat bathi resik|Pheton Holdings - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma